The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence
Despite the success of liver transplantation, long-term complications remain, including de novo malignancies, metabolic syndrome, and the recurrence of hepatitis C virus (HCV) and hepatocellular carcinoma (HCC). The current mainstay of treatment, calcineurin inhibitors (CNIs), can also worsen posttr...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Journal of Transplantation |
Online Access: | http://dx.doi.org/10.1155/2014/845438 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|